Mulazim Hussain Asim

Dr. Mulazim Hussain Asim

University of Sargodha, Sargodha, Punjab, Pakistan
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
INImran Nazir
Imran Nazir
Mulazim Hussain AsimMulazim Hussain Asim
Mulazim Hussain Asim
ADAida Dizdarević
Aida Dizdarević
ABAndreas Bernkop-Schnürch
Andreas Bernkop-Schnürch

1 June 2019 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
AJAamir Jalil
Aamir Jalil
Mulazim Hussain AsimMulazim Hussain Asim
Mulazim Hussain Asim
NLNguyet-Minh Nguyen Le
Nguyet-Minh Nguyen Le
FLFlavia Laffleur
Flavia Laffleur
BMBarbara Matuszczak
Barbara Matuszczak
ABAndreas Bernkop-Schnürch
Andreas Bernkop-Schnürch

14 March 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AAAmina Arshad
Amina Arshad
SAShumaila Arshad
Shumaila Arshad
ALAlamgeer
Alamgeer
AMArshad Mahmood
Arshad Mahmood
Mulazim Hussain AsimMulazim Hussain Asim
Mulazim Hussain Asim
AHAhmed Raza Hashmi
Ahmed Raza Hashmi

1 April 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
Mulazim Hussain AsimMulazim Hussain Asim
Mulazim Hussain Asim
MIMuhammad Ijaz
Muhammad Ijaz
AMArshad Mahmood
Arshad Mahmood
PKPatrick Knoll
Patrick Knoll
AJAamir Jalil
Aamir Jalil
ABAndreas Bernkop-Schnürch
Andreas Bernkop-Schnürch
Thiolated β-cyclodextrin (β-CD) has the potential to enhance mucoadhesive and permeation enhancing properties on ocular mucosa. Thiolated β-CD was synthesized via replacement of all primary hydroxyl groups on β-CD backbone by halogen followed by substitution with thiol groups. The structure was confirmed by FT-IR and 1H NMR spectroscopy. Thiolated CD was characterized for hemolytic effect, ocular irritation, solubility enhancement, viscoelastic behavior and mucoadhesive properties. Moreover, the permeation enhancing effect of thiolated oligomer on different ocular tissues including conjunctiva, sclera and cornea was evaluated with sodium fluorescein (Na-Flu) as a marker. Thiolated β-CD displayed 5360 ± 412 µmol/g thiol groups. The newly synthesized oligomer did not show any hemolytic effect on red blood cells at a concentration of 0.5% (m/v) for an incubation period of 3 h and minimal corneal irritation effects without any inflammation within 72 h. Thiolated β-CD exhibited a 5.3-fold improved aqueous solubility as compared to the unmodified β-CD. Thiolated oligomer (0.5% m/v) enhanced the viscosity of mucus up to 6.2-fold within 4 h and provided a 26-fold prolonged ocular residence time due to mucoadhesion. Moreover, 0.5% (m/v) thiolated β-CD enhanced the permeation of Na-Flu 9.6-, 7.1- and 5.3-fold on conjunctiva, sclera and cornea, respectively. Based on these findings, thiolated β-CD might be a promising auxiliary agent for ocular drug delivery.

1 March 2021 in Journal of Colloid and Interface Science
Verified
Journal Article
Open access
FSFaezeh Sharifi
Faezeh Sharifi
MJMansour Jahangiri
Mansour Jahangiri
INImran Nazir
Imran Nazir
Mulazim Hussain AsimMulazim Hussain Asim
Mulazim Hussain Asim
PEPedram Ebrahimnejad
Pedram Ebrahimnejad
ABAndreas Bernkop-Schnürch
Andreas Bernkop-Schnürch
Simple zwitterions used as auxiliary agents might have the potential to change the zeta potential of oil-in-water (o/w) nanoemulsions on the mucosa. The zwitterion phosphorylated tyramine (p-Tyr) was synthesized by phosphorylation of Boc-tyramine (Boc-Tyr) using phosphoryl chloride (POCl3). It was incorporated with 2% (m/v) in a self-emulsifying lipophilic phase comprising Captex 35, Cremophor EL, Capmul MCM and glycerol 85 at a ratio of 30:30:30:10 v/v. Phosphate release and resulting change in zeta potential were evaluated by incubating p-Tyr containing nanoemulsion with isolated intestinal alkaline phosphatase (AP). Mucus permeating behavior was evaluated across mucus obtained from porcine small intestinal mucosa. Subsequently, cellular uptake studies were accomplished on Caco-2 cells. The p-Tyr loaded nanoemulsion exhibited a mean droplet size of 43 ± 1.7 nm and zeta potential of -8.40 mV. Phosphate moieties were rapidly cleaved from p-Tyr loaded nanoemulsions after incubation with isolated AP resulting in a shift in zeta potential from -8.40 mV to +1.2 mV. p-Tyr loaded nanoemulsion revealed a significantly (p ≤ 0.001) improved mucus permeation compared to the same nanoemulsion having been pre-treated with AP. Cellular uptake of the zeta potential changing oily droplets was 2.4-fold improved. Phosphorylated zwitterions seem to be an alternative to cationic surfactants and considered as promising auxiliary agents for zeta potential changing nanoemulsions.

1 November 2021 in Acta Biomaterialia
Verified
Journal Article
Open access
PKPatrick Knoll
Patrick Knoll
NLNguyet-Minh Nguyen Le
Nguyet-Minh Nguyen Le
RWRichard Wibel
Richard Wibel
RBRandi Angela Baus
Randi Angela Baus
Gergely KaliGergely Kali
Gergely Kali
ABAndreas Bernkop-Schnürch
Andreas Bernkop-Schnürch
In recent decades, three generations of thiomers have been developed with the main purpose of obtaining enhanced interactions with mucosal tissues. Therefore, many different types of thiolated ligands have been generated and attached to polymeric backbones. The aim of this study was to synthesize all three generations of thiomers and to directly compare their properties regarding mucus penetration and mucoadhesion. Starting from pectin, the unprotected thiomer pectin-cysteine (Pec-Cys), the preactivated S-protected thiomer pectin-cysteine-mercaptonicotinic acid (Pec-Cys-MNA) and the less reactive S-protected thiomer pectin-cysteine-glutathione (Pec-Cys-GSH) were synthesized and characterised by FT-IR, NMR, and colorimetric studies. The polymers were evaluated regarding their cytotoxicity, swelling behaviour, viscosity after mixing with mucus, mucus diffusion, penetration into mucosa, and mucoadhesion. The amount of the three ligands (Cys, Cys-MNA and Cys-GSH) bound to the polymer was determined to be in the range of 193-196 µmol/g. All polymers showed no cytotoxicity. Viscosity of the mixture of Pec-Cys-MNA and Pec-Cys-GSH with mucus increased 21.5- and 26.7-fold, respectively, compared to the unmodified polymer within 3 hours. Swelling, mucoadhesion, interpenetration and mucus diffusion were increased in the following rank order: Pec-Cys < Pec-Cys-MNA < Pec-Cys-GSH. Results of mucoadhesion study indicated a 7.4 and 8.1-fold increase of Pec-Cys-MNA and Pec-Cys-GSH, respectively, compared to the unmodified polymer. As the less reactive S-protected thiomer exhibited higher mucoadhesive properties than the other thiomers, this study provides evidence for the superior mucoadhesion of 3rd generation thiomers. STATEMENT OF SIGNIFICANCE: Three generations of thiolated polymers have been developed bearing different types of thiol ligands with the main purpose of enhancing mucus interactions. In this study, all generations were synthesized on the polymeric backbone of pectin for the first time to directly compare their mucus penetrating and mucoadhesive properties. 1st generation exhibited covalently bound L-cysteine moieties. For 2nd generation, thiols of cysteines were S-protected with 2-mercaptonicotinic acid (MNA), resulting in high reactive disulfide bonds. 3rd generation was synthesized by a thiol/disulfide exchange of glutathione with MNA, producing a less reactive disulfide bond. Mucus penetrating and mucoadhesive properties were found to be increased as follows: 1st generation < 2nd generation < 3rd generation. According to these results, the thiomer of 3rd generation represents a promising excipient with strong mucoadhesion.